Full Description
This textbook provides a comprehensive reference on adult vaccines and immunization practices tailored to the European context. The reader is guided from assessing the health burden of vaccine-preventable infections to evaluating the cost-effectiveness of new adult vaccination schedules, introducing and establishing such initiatives, and communicating and managing vaccination programs. The authors update on routine and new vaccines for a number of common pathogens in Europe, such as SARS-CoV-2, RSV and influenza, and also provide information on travel-related vaccinations. The book discusses in detail individualized, risk-based vaccination for different patient groups and also provides insights into current pipeline development, and an outlook on the future prospects for adult vaccination.
All editors are part of the Adult Immunization Board (AIB) created in November 2022. The AIB is a European platform that brings together experts to address key challenges in adult vaccination. The goal is to promote evidence-based policies, knowledge sharing, and cross-country collaboration to improve adult immunization. The AIB secretariat based at the University of Antwerp and University of Florence is responsible for the operational and scientific tasks of the AIB and took the lead in coordinating the writing of this book supported by its AIB advisors and other selected experts.
Contents
Part I: General Aspects of Vaccines And Vaccination for Adults.- Chapter 1. Introduction on Adult Caccination.- Chapter 2. Overview of Licensed Vaccines for Adults in Europe.- Chapter 3. Understanding the Concepts of Vaccine Immunology, Efficacy And Effectiveness.- Chapter 4. The Current Status and Evolution of Vaccination Programs for Adults in Europe.- Chapter 5. Strategies for Introducing and Implementing Vaccines for Adults into National Immunization Programmes in Europe.- Chapter 6. Economic Evaluations of Vaccines for Adults and Programs in Europe.- Chapter 7. Confidence in Adult Vaccination in Europe: Challenges and Solutions.- Chapter 8. Pharmacovigilance of Vaccines.- Chapter 9. Adult Vaccination Policy in Europe: Governance and Key Stakeholders.- Chapter 10. Vaccines Manufacturing Process.- Part II: Routine Vaccines and Vaccinations For Adults.- Chapter 11. COVID-19 and SARS-CoV-2 Vaccines in European Adults.- Chapter 12. Herpes Zoster Vaccination.- Chapter 13. Seasonal Influenza Vaccination.- Chapter 14. Pneumococcal Vaccination .- Chapter 15. Respiratory Syncytial Virus Vaccination.- Chapter 16. TBE vaccination.- Chapter 17. Tetanus, Diphtheria, And Pertussis Vaccination In Adults.- Part III: Catch-up Vaccines And Vaccinations for Adults.- Chapter 18. Catching up Child and Adolescent Vaccinations in Adults.- Chapter 19. Vaccination of Pregnant Women.- chapter 20. Vaccination of Immunocompromised Subjects.- Chapter 21. Mpox and Vaccination: Lessons from Outbreaks.- Chapter 22. Adult vaccines for Travel Outside Europe.- Chapter 23. Adult Vaccines For Occupational Activities.- Part V: Future perspective for Vaccines and Vaccinations for Adults.- Chapter 24. New Vaccines for Adults In Research And Development.
